SG11201906431UA - Method for the treatment of thromboembolism - Google Patents
Method for the treatment of thromboembolismInfo
- Publication number
- SG11201906431UA SG11201906431UA SG11201906431UA SG11201906431UA SG11201906431UA SG 11201906431U A SG11201906431U A SG 11201906431UA SG 11201906431U A SG11201906431U A SG 11201906431UA SG 11201906431U A SG11201906431U A SG 11201906431UA SG 11201906431U A SG11201906431U A SG 11201906431UA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- artery
- thromboembolism
- lobe
- pct
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B17/22004—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves
- A61B17/22012—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves in direct contact with, or very close to, the obstruction or concrement
- A61B17/2202—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves in direct contact with, or very close to, the obstruction or concrement the ultrasound transducer being inside patient's body at the distal end of the catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0092—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin using ultrasonic, sonic or infrasonic vibrations, e.g. phonophoresis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22082—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for after introduction of a substance
- A61B2017/22084—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for after introduction of a substance stone- or thrombus-dissolving
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22082—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for after introduction of a substance
- A61B2017/22088—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for after introduction of a substance ultrasound absorbing, drug activated by ultrasound
Abstract
PeerpalmonerV artery Pulmonary artery Irtmk Ilm el lower pan - weary Whey Embolus Pylmenery artery btmk EKOS catheter seeks Main Pahanary artery LIPP°, Pubaanan , erten+ be lobe Mammy seementel artery bra HG. (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 02 August 2018 (02.08.2018) WIP0 I PCT omit VIII °nolo offi 11E11111E1mo oimIE (10) International Publication Number WO 2018/138634 Al (51) International Patent Classification: A61K 38/00 (2006.01) A61P 7/02 (2006.01) (21) International Application Number: PCT/IB2018/050403 (22) International Filing Date: 23 January 2018 (23.01.2018) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 62/449,966 24 January 2017 (24.01.2017) US (71) Applicant: EKOS CORPORATION [US/US]; 11911 North Creek Parkway S., Bothell, Washington WA 98011 (US). (72) Inventor: ALLEN, Lynn; C/O Ekos Corporation, 11911 North Creek Parkway S., Bothell, Washington WA 98011 (US). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Published: with international search report (Art. 21(3)) in black and white; the international application as filed contained color or greyscale and is available for download from PATENTSCOPE (54) Title: METHOD FOR THE TREATMENT OF THROMBOEMBOLISM (57) : A method for the treatment of thromboembolism comprising administering a thrombolytic agent directly to the thromboembolism in the Main presence of ultrasound. The total dose of thrombolytic agent administered is W O 20 18/ 13863 4 Al Dietellevax Wear lobe lobe pufatanary teebnental artery branches between 1 and 12mg and the time over which the total dose is delivered is less than 15 hours.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762449966P | 2017-01-24 | 2017-01-24 | |
PCT/IB2018/050403 WO2018138634A1 (en) | 2017-01-24 | 2018-01-23 | Method for the treatment of thromboembolism |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201906431UA true SG11201906431UA (en) | 2019-08-27 |
Family
ID=61224209
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201906431UA SG11201906431UA (en) | 2017-01-24 | 2018-01-23 | Method for the treatment of thromboembolism |
Country Status (10)
Country | Link |
---|---|
US (1) | US20180206867A1 (en) |
EP (3) | EP4272818A3 (en) |
JP (2) | JP2020506907A (en) |
KR (1) | KR20190110095A (en) |
CN (1) | CN110214015A (en) |
AU (1) | AU2018212778A1 (en) |
CA (1) | CA3050858A1 (en) |
SG (1) | SG11201906431UA (en) |
TW (1) | TW201827074A (en) |
WO (1) | WO2018138634A1 (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE520362T1 (en) | 2001-12-03 | 2011-09-15 | Ekos Corp | CATHETER WITH MULTIPLE ULTRASONIC EMITTING PARTS |
US10182833B2 (en) | 2007-01-08 | 2019-01-22 | Ekos Corporation | Power parameters for ultrasonic catheter |
EP2494932B1 (en) | 2007-06-22 | 2020-05-20 | Ekos Corporation | Apparatus for treatment of intracranial hemorrhages |
US10656025B2 (en) | 2015-06-10 | 2020-05-19 | Ekos Corporation | Ultrasound catheter |
JP2020103418A (en) * | 2018-12-26 | 2020-07-09 | 株式会社三洋物産 | Game machine |
US11717139B2 (en) | 2019-06-19 | 2023-08-08 | Bolt Medical, Inc. | Plasma creation via nonaqueous optical breakdown of laser pulse energy for breakup of vascular calcium |
WO2020256898A1 (en) | 2019-06-19 | 2020-12-24 | Boston Scientific Scimed, Inc. | Balloon surface photoacoustic pressure wave generation to disrupt vascular lesions |
US11660427B2 (en) | 2019-06-24 | 2023-05-30 | Boston Scientific Scimed, Inc. | Superheating system for inertial impulse generation to disrupt vascular lesions |
US20200406010A1 (en) | 2019-06-26 | 2020-12-31 | Boston Scientific Scimed, Inc. | Side light direction plasma system to disrupt vascular lesions |
US10792054B1 (en) | 2019-07-11 | 2020-10-06 | Eduardo Lorenzo | Catheter for thromboembolic disease with mechanic waves, injection and ejection |
US11583339B2 (en) | 2019-10-31 | 2023-02-21 | Bolt Medical, Inc. | Asymmetrical balloon for intravascular lithotripsy device and method |
US11672599B2 (en) | 2020-03-09 | 2023-06-13 | Bolt Medical, Inc. | Acoustic performance monitoring system and method within intravascular lithotripsy device |
US20210290286A1 (en) | 2020-03-18 | 2021-09-23 | Bolt Medical, Inc. | Optical analyzer assembly and method for intravascular lithotripsy device |
US11707323B2 (en) | 2020-04-03 | 2023-07-25 | Bolt Medical, Inc. | Electrical analyzer assembly for intravascular lithotripsy device |
JP2021186294A (en) * | 2020-05-29 | 2021-12-13 | 株式会社三洋物産 | Game machine |
US11672585B2 (en) | 2021-01-12 | 2023-06-13 | Bolt Medical, Inc. | Balloon assembly for valvuloplasty catheter system |
US11648057B2 (en) | 2021-05-10 | 2023-05-16 | Bolt Medical, Inc. | Optical analyzer assembly with safety shutdown system for intravascular lithotripsy device |
US11806075B2 (en) | 2021-06-07 | 2023-11-07 | Bolt Medical, Inc. | Active alignment system and method for laser optical coupling |
US11839391B2 (en) | 2021-12-14 | 2023-12-12 | Bolt Medical, Inc. | Optical emitter housing assembly for intravascular lithotripsy device |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5399158A (en) * | 1990-05-31 | 1995-03-21 | The United States Of America As Represented By The Secretary Of The Army | Method of lysing thrombi |
US5447509A (en) * | 1991-01-11 | 1995-09-05 | Baxter International Inc. | Ultrasound catheter system having modulated output with feedback control |
JP3462561B2 (en) * | 1994-04-01 | 2003-11-05 | 立花 克郎 | Drug administration device |
US5509896A (en) * | 1994-09-09 | 1996-04-23 | Coraje, Inc. | Enhancement of thrombolysis with external ultrasound |
US5945432A (en) * | 1995-12-22 | 1999-08-31 | The University Of Vermont And State Agricultural College | Thrombolytic agents and thienopyridine derivatives in acute stroke |
US6623444B2 (en) * | 2001-03-21 | 2003-09-23 | Advanced Medical Applications, Inc. | Ultrasonic catheter drug delivery method and device |
ATE520362T1 (en) | 2001-12-03 | 2011-09-15 | Ekos Corp | CATHETER WITH MULTIPLE ULTRASONIC EMITTING PARTS |
AU2003265898A1 (en) * | 2002-09-05 | 2004-03-29 | Genentech, Inc. | Infusion catheter having an integrated doppler transducer |
EP2015846A2 (en) * | 2006-04-24 | 2009-01-21 | Ekos Corporation | Ultrasound therapy system |
TWI439282B (en) * | 2006-08-29 | 2014-06-01 | Genentech Inc | Method of treating stroke with thrombolytic agent |
WO2008086372A1 (en) | 2007-01-08 | 2008-07-17 | Ekos Corporation | Power parameters for ultrasonic catheter |
JP2012513292A (en) * | 2008-12-23 | 2012-06-14 | シルク・ロード・メディカル・インコーポレイテッド | Method and system for treating acute ischemic stroke |
US20110082396A1 (en) * | 2009-10-06 | 2011-04-07 | Wallace Michael P | Ultrasound-enhanced stenosis therapy |
CN105361923B (en) * | 2010-08-27 | 2018-02-02 | Ekos公司 | For treating the method and apparatus intracranialed hemorrhage |
US11458290B2 (en) * | 2011-05-11 | 2022-10-04 | Ekos Corporation | Ultrasound system |
CA2902713C (en) * | 2013-03-14 | 2021-06-01 | Ekos Corporation | Method and apparatus for drug delivery to a target site |
-
2018
- 2018-01-23 AU AU2018212778A patent/AU2018212778A1/en active Pending
- 2018-01-23 JP JP2019539808A patent/JP2020506907A/en active Pending
- 2018-01-23 EP EP23193805.1A patent/EP4272818A3/en active Pending
- 2018-01-23 TW TW107102370A patent/TW201827074A/en unknown
- 2018-01-23 CN CN201880007480.0A patent/CN110214015A/en active Pending
- 2018-01-23 SG SG11201906431UA patent/SG11201906431UA/en unknown
- 2018-01-23 WO PCT/IB2018/050403 patent/WO2018138634A1/en unknown
- 2018-01-23 EP EP18705178.4A patent/EP3573635B1/en active Active
- 2018-01-23 CA CA3050858A patent/CA3050858A1/en active Pending
- 2018-01-23 EP EP21173294.6A patent/EP3936140B1/en active Active
- 2018-01-23 US US15/878,269 patent/US20180206867A1/en active Pending
- 2018-01-23 KR KR1020197020966A patent/KR20190110095A/en not_active IP Right Cessation
-
2023
- 2023-05-24 JP JP2023085321A patent/JP2023120202A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CA3050858A1 (en) | 2018-08-02 |
EP3573635B1 (en) | 2021-05-12 |
EP3936140A1 (en) | 2022-01-12 |
EP3573635A1 (en) | 2019-12-04 |
EP4272818A2 (en) | 2023-11-08 |
AU2018212778A1 (en) | 2019-07-11 |
US20180206867A1 (en) | 2018-07-26 |
KR20190110095A (en) | 2019-09-27 |
EP3936140B1 (en) | 2023-08-30 |
CN110214015A (en) | 2019-09-06 |
JP2020506907A (en) | 2020-03-05 |
JP2023120202A (en) | 2023-08-29 |
TW201827074A (en) | 2018-08-01 |
WO2018138634A1 (en) | 2018-08-02 |
EP4272818A3 (en) | 2024-02-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11201906431UA (en) | Method for the treatment of thromboembolism | |
SG11201907034PA (en) | Methods of treating influenza | |
SG11201811431VA (en) | Multispecific antibodies against cd40 and cd137 | |
SG11201811432WA (en) | Rna for cancer therapy | |
SG11201909963YA (en) | Methods for treating dravet syndrome | |
SG11201407580YA (en) | Composition comprising two antibodies engineered to have reduced and increased effector function | |
SG11201804263PA (en) | Cancer treatment using 2-deoxy-2-fluoro-l-fucose in combination with a checkpoint inhibitor | |
SG11201908971RA (en) | Erbb-2 and erbb3 binding bispecific antibodies for use in the treatment f cells that have an nrg1 fusion gene | |
SG11201810420YA (en) | Antibodies to alpha-synuclein and uses thereof | |
SG11201901996UA (en) | Formulations of ( r)-2-amino-3-phenylpropyl carbamate | |
SG11201407340YA (en) | Treatment of myelosuppression | |
SG11201808222RA (en) | Methods of treatment of cholestatic diseases | |
SG11201901534VA (en) | Combination therapy with controlled-release cnp agonists | |
SG11201805311XA (en) | Method of treating a mammal, including human, against cancer using methionine and asparagine depletion | |
SG11201906959RA (en) | Aryl hydrocarbon receptor (ahr) modulator compounds | |
SG11201807827VA (en) | Process for the preparation of pegylated drug-linkers and intermediates thereof | |
SG11201908326YA (en) | Methods of treating neurodegenerative diseases | |
SG11201906436VA (en) | Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same | |
SG11201809882XA (en) | Pharmaceutical combinations for treating cancer | |
SG11201804587QA (en) | Isoindole compounds | |
SG11201903061YA (en) | Combination treatments comprising administration of imidazopyrazinones | |
SG11201805755SA (en) | Methods of administering hepcidin | |
SG11201901063SA (en) | Therapeutic agents for neurodegenerative diseases | |
SG11201907927SA (en) | Binding molecules that specifically bind to tau | |
SG11201908513RA (en) | Peptides for treatment of diabetes |